（ 研究業績 ） output

すべて 論文

  • 37. Application of BCG-CWS as a systemic adjuvant by using nanoparticulation technology.

    Masuda H, Nakamura T* (equal contribution to 1st author), Noma Y, Harashima H*.
    Mol Pharm 15: 5762-5771 (2018).

    DOI : 10.1021/acs.molpharmaceut.8b00919.

    論文

  • 36. DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.

    Kawai M, Nakamura T, Miura N, Maeta M, Tanaka H, Ueda K, Higashi K, Moribe K, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H*.
    Nanomedicine 14: 2587-2597 (2018).

    DOI : 10.1016/j.nano.2018.08.006.

    論文

  • 35. Reducing the cytotoxicity of lipid nanoparticles associated with a fusogenic-cationic lipid in a natural killer cell line by introducing a polycation based siRNA core.

    Nakamura T, Yamada K, Fujiwara Y, Sato Y, Harashima H*.
    Mol Pharm 15: 2142-2150 (2018).

    DOI : 10.1021/acs.molpharmaceut.7b01166.

    論文

  • 34. Liposome microencapsulation for the surface modification and improved entrapment of cytochrome c for targeted delivery.

    Kajimoto K*, Katsumi T, Nakamura T, Kataoka M, Harashima H.
    J American Oil Chemists Society 95: 101-109 (2018).

    DOI : 10.1002/aocs.12026

    論文

  • 33. Modifying antigen-encapsulating liposomes with KALA facilitates MHC class-I antigen presentation and enhances anti-tumor effects.

    Miura N, Akita H*, Tateshita N, Nakamura T, Harashima H*.
    Mol Ther 25: 1003-1013 (2017).

    DOI : 10.1016/j.ymthe.2017.01.020.

    論文

  • 32. Modifying cationic liposomes with cholesteryl-PEG prevents their aggregation in human urine and enhances cellular uptake by bladder cancer cells.

    Nakamura T, Noma Y, Sakurai Y, Harashima H*.
    Biol Pharm Bull 40: 234-237 (2017).

    DOI : 10.1248/bpb.b16-00770.

    論文

  • 31. Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines.

    Nakamura T, Kuroi M, Fujiwara Y, Warashina S, Sato Y, Harashima H*.
    Sci Rep 6: 37849 (2016).

    DOI : 10.1038/srep37849.

    論文

  • 30. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.

    Warashina S, Nakamura T, Sato Y, Fujiwara Y, Hyodo M, Hatakeyama H, Harashima H*.
    J Control Release 225: 183-191 (2016).

    DOI : 10.1016/j.jconrel.2016.01.042.

    論文

  • 29. Tri-membrane nanoparticles produced by combining liposome fusion and a novel patchwork of bicelles to overcome endosomal and nuclear membrane barriers to cargo delivery.

    Yamada A, Mitsueda A, Ueda M, Hama S, Warashina S, Nakamura T, Harashima H, Kogure K*.
    Biomater Sci 4: 439-447 (2016).

    DOI : 10.1039/c5bm00327j.

    論文

  • 28. In vivo inverse correlation in the activation of natural killer T cells through dual-signal stimulation via a combination of α-galactosylceramide-loaded liposomes and interleukin-12.

    Abdelmegeed H, Nakamura T, Harashima H*.
    J Pharm Sci 105: 250-256 (2016).

    DOI : 10.1016/j.xphs.2015.10.009.

    論文